Skip to main content
Have a personal or library account? Click to login
Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo Cover

Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo

Acta Pharmaceutica
Volume 66 (2016): Issue 1 (March 2016)
By: ,  ,  ,  ,  ,   and    
Open Access
|Mar 2016
References

References

  1. 1. S. A. Thomas, Anti-HIV drug distribution to the central nervous system,(2004) 1313–1324; DOI: 10.2174/1381612043384835.
    Open DOISearch in Google Scholar
  2. 2. J. A. Zastre, G. N. Chan, P. T. Ronaldson, M. Ramaswamy, P. O. Couraud, I. A. Romero, B. Weksler, M. Bendayan and R. Bendayan, Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line,(2009) 1023–1036; DOI: 10.1002/jnr.21898.
    Open DOISearch in Google Scholar
  3. 3. M. Ahn, S. Ghaemmaghami, Y. Huang, P. W. Phuan, B. C. May, K. Giles, S. J. DeArmond and S. B. Prusiner, Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter,7 (2012) e39112; DOI: 10.1371/journal.pone.0039112.
    Open DOISearch in Google Scholar
  4. 4. D. Pal, D. Kwatra, M. Minocha, D. K. Paturi, B. Budda and A. K. Mitra, Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals,(2011) 959–971; DOI: 10.1016/j.lfs.2010.09.012.
    Open DOISearch in Google Scholar
  5. 5. A. Antinori, G. Arendt, J. T. Becker, B. J. Brew, D. A. Byrd, M. Cherner, D. B. Clifford, P. Cinque, L. G. Epstein, K. Goodkin, M. Gisslen, I. Grant, R. K. Heaton, J. Joseph, K. Marder, C. M. Marra, J. C. McArthur, M. Nunn, R. W. Price, L. Pulliam, K. R. Robertson, N. Sacktor, V. Valcour and V. E. Wojna, Updated research nosology for HIV-associated neurocognitive disorders,(2007) 1789–1799; DOI: 10.1212/01.WNL.0000287431.88658.8b.
    Open DOISearch in Google Scholar
  6. 6. L. Varatharajan and S. A. Thomas, The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research,(2009) A99–A109; DOI: 10.1016/j.antiviral.2008.12.013.
    Open DOISearch in Google Scholar
  7. 7. J. W. Polli, J. L. Jarrett, S. D. Studenberg, J. E. Humphreys, S. W. Dennis, K. R. Brouwer and J. L. Woolley, Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor,(1999) 1206–1212; DOI: 10.1023/A:1018941328702.
    Open DOISearch in Google Scholar
  8. 8. E. F. Choo, B. Leake, C. Wandel, H. Imamura, A. J. Wood, G. R. Wilkinson and R. B. Kim, Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes,(2000) 655–60.
    Search in Google Scholar
  9. 9. S. Park and P. J. Sinko, P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice,(2005) 1249–1256; DOI:10.1124/jpet.104.076216.
    Open DOISearch in Google Scholar
  10. 10. C. J. Bachmeier, T. J. Spitzenberger, W. F. Elmquist and D. W. Miller, Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood–brain barrier,(2005) 1259–1268; DOI: 10.1007/s11095-005-5271-y.
    Open DOISearch in Google Scholar
  11. 11. M. Hamidi, Role of P-glycoprotein in tissue uptake of indinavir in rat,(2006) 991–998; DOI: 10.1016/j.lfs.2006.05.010.
    Open DOISearch in Google Scholar
  12. 12. U. Roy, C. Bulot, K. Höner zu Bentrup and D. Mondal, Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir,(2013) e75374; DOI: 10.1371/journal.pone.0075374.
    Open DOISearch in Google Scholar
  13. 13. Z. Binkhathlan and A. Lavasanifar, P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives,(2013) 326–346; DOI: 10.2174/15680096113139990076.
    Open DOISearch in Google Scholar
  14. 14. A. Palmeira, E. Sousa, M. H. Vasconcelos and M. M. Pinto, Three decades of P-gp inhibitors: skimming through several generations and scaffolds,(2012) 1946–2025; DOI: 10.2174/092986712800167392.
    Open DOISearch in Google Scholar
  15. 15. H. A. Namanja, D. Emmert, D. A. Davis, C. Campos, D. S. Miller, C. A. Hrycyna and J. Chmielewski, Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers,(2012) 2976–2980; DOI: 10.1021/ja206867t.
    Open DOISearch in Google Scholar
  16. 16. M. T. Sheu, Y. B. Liou, Y. H. Kao, Y. K. Lin and H. O. Ho, A quantitative structure-activity relationship for the modulation effects of flavonoids on p-glycoprotein-mediated transport,(Tokyo)(2010) 1187–1194; DOI: 10.1248/cpb.58.1187.
    Open DOISearch in Google Scholar
  17. 17. P. Limtrakul, O. Khantamat and K. Pintha, Inhibition of P-glycoprotein function and expression by kaempferol and quercetin,(2005) 86–95; DOI: 10.1179/joc.2005.17.1.86.
    Open DOISearch in Google Scholar
  18. 18. D. Pal and A. K. Mitra, MDR- and CYP3A4-mediated drug-herbal interactions,(2006) 2131–2145; DOI: 10.1016/j.lfs.2005.12.010.
    Open DOISearch in Google Scholar
  19. 19. J. Patel, B. Buddha, S. Dey, D. Pal and A. K. Mitra, In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity,(2004) 262–277.
    Search in Google Scholar
  20. 20. S. Zhou, X. Feng, P. Kestell, J. W. Paxton, B. C. Baguley and E. Chan, Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells,(2005) 513–524; DOI: 10.1016/j.ejps.2005.01.006.
    Open DOISearch in Google Scholar
  21. 21. X.Y. Yu, S. G. Lin, Z. W. Zhou, X. Chen, J. Liang, X. Q. Yu, B. Chowbay, J. Y. Wen, W. Duan, E. Chan, X.T. Li, J. Cao, C. G. Li, C. C. Xue and S. F. Zhou, Role of P-glycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of(2007) 1668–1690; DOI: 10.1007/s11095-007-9297-1.
    Open DOISearch in Google Scholar
  22. 22. Y. J. Moon and M. E. Morris, Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats,(2007) 865–872; DOI: 10.1021/mp7000928.
    Open DOISearch in Google Scholar
  23. 23. J. G. Sarver, W. A. Klis, J. P. Byers and P. W. Erhardt, Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein,(2002) 29–34; DOI: 10.1177/108705710200700105.
    Open DOISearch in Google Scholar
  24. 24. K. Berginc, I. Milisav and A. Kristl, Garlic flavonoids and organosulfur compounds: Impact on the hepatic pharmacokinetics of saquinavir and darunavir,(2010) 521–530; DOI: JST.JSTAGE/dmpk/DMPK-10-RG-053 [pii].
    Open DOISearch in Google Scholar
  25. 25. A. Di Pietro, G. Conseil, J. M. Pérez-Victoria, G. Dayan, H. Baubichon-Cortay, D. Trompier, E. Steinfels, J. M. Jault, H. de Wet, M. Maitrejean, G. Comte, A. Boumendjel, A. M. Mariotte, C. Dumontet, D. B. McIntosh, A. Goffeau, S. Castanys, F. Gamarro and D. Barron, Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters,(2002) 307–322; DOI: 10.1007/s00018-002-8424-8.
    Open DOISearch in Google Scholar
  26. 26. J. B. Vaidyanathan and T. Walle, Cellular uptake and efflux of the tea flavonoid (–)epicatechin-3-gallate in the human intestinal cell line Caco-2,(2003) 745–752; DOI: 10.1124/jpet.103.054296.
    Open DOISearch in Google Scholar
  27. 27. Y. Li, J. L. Revalde, G. Reid and J. W. Paxton, Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer,(2010) 590–611; DOI: 10.3109/03602531003758690.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/acph-2016-0009 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 97 - 107
Accepted on: Sep 28, 2015
Published on: Mar 7, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
quercetin,
flavonoids,
ritonavir,
blood-brain barrier,
pharmacokinetics
Related subjects:
Pharmacy,
Pharmacy, other

© 2016 Gongwen Liang, Na Li, Liping Ma, Zhonglian Qian, Yuwen Sun, Luwen Shi, Libo Zhao, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 66 (2016): Issue 1 (March 2016)
Previous article
Next article